Table 3.
Parameter | Single Ventricle, n=47 | Two Ventricle, n=10 | P value |
---|---|---|---|
rSO2 <45% AUC (%-min) | 257 (4–2003) | 0 (0–0) | <0.001 |
rSO2 mean (%) | 57.8 ± 6.1 | 76.1 ± 5.1 | <0.001 |
Cardiac arrest, n(%) | 2 (4) | 0 | 1 |
Extracorporeal membrane oxygenation, n(%) | 2 (4) | 0 | 1 |
Mechanical ventilation days | 4 (4–7) | 4 (3–5) | 0.262 |
Fentanyl equivalents, 1st 72 h (mcg/kg) | 80 (46–157) | 24 (18–94) | 0.041 |
Benzodiazepine dose, 1st 72 h (mg/kg) | 2.15 (0.33–6.09) | 0.81 (0.04–1.60) | 0.145 |
Intensive care unit length of stay (days) | 9 (7–16) | 8 (7–8) | 0.151 |
Hospital length of stay (days) | 34 (24–54) | 26 (22–37) | 0.123 |
Hospital discharge mortality (n,%) | 2 (4) | 0 | 1 |
Mortality, 1st 12 months (n,%) | 10 (21) | 0 | 0.183 |
AUC, area under the curve; RCP, regional cerebral perfusion; rSO2; regional cerebral oxygen saturation. Data expressed as mean ± standard deviation, or median (25th–75th percentile).
p≤0.05.